The long-read sequencing market is expected to reach USD 3,129 million by 2029 from USD 758 million in 2024, at a CAGR of 32.8% during the forecast period. The main forces behind the expansion of this market are the rising frequency of complex genetic disorders, expanding applications of long-read sequencing, and the technological development in genome sequencing aiding in the adoption of third-generation sequencing. The global long-read sequencing market is consolidated with top players such as PacBio (US), Oxford Nanopore Technologies plc. (UK), Illumina, Inc. (US). The market players have adopted various strategies such as new product launches, collaborations, and geographical expansions to strengthen their position in the global long-read sequencing market.
The long-read sequencing market is transforming genomics by enabling researchers to analyze complex DNA regions, structural variants, epigenetics, and full-length transcripts with far greater accuracy than traditional short-read technologies. As precision medicine, cancer genomics, and rare disease research accelerate globally, several biotechnology leaders are shaping the competitive landscape of this fast-growing sector.
Download PDF brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=140422082
Here are the key companies driving innovation in the long-read sequencing market.
Market Leaders Dominating Long-Read Sequencing
1. Pacific Biosciences
Often known as PacBio, the company is one of the strongest innovators in long-read sequencing through its proprietary Single Molecule Real-Time (SMRT) sequencing technology. PacBio’s HiFi sequencing platform is widely recognized for delivering highly accurate long reads, making it especially valuable for:
- Whole genome sequencing
- Structural variant detection
- Rare disease analysis
- Cancer genomics
- Transcriptomics
Its Revio and Sequel systems are increasingly adopted by research institutes and clinical laboratories worldwide. Industry analysts consistently position PacBio among the dominant players in the market.
2. Oxford Nanopore Technologies
Oxford Nanopore Technologies (ONT) revolutionized sequencing with nanopore-based platforms capable of real-time DNA and RNA analysis. Its portable MinION device became particularly popular for field-based genomics, infectious disease surveillance, and decentralized testing.
Key advantages of ONT platforms include:
- Ultra-long reads
- Portable sequencing devices
- Real-time data generation
- Flexible throughput scalability
- Direct RNA sequencing
The company continues expanding through collaborations with universities, healthcare organizations, and pharmaceutical companies. Analysts frequently identify ONT and PacBio as the two dominant “pure-play” long-read sequencing leaders globally.
3. Illumina
Although Illumina is historically associated with short-read sequencing, the company has made strategic moves into long-read genomics through innovations such as Illumina Complete Long Read technology.
Illumina remains highly influential because of:
- Massive installed sequencing base
- Strong genomics ecosystem
- Advanced bioinformatics capabilities
- Broad clinical adoption
The company’s entry into long-read workflows is intensifying competition within the market.
Emerging and Expanding Companies
4. BGI Genomics
BGI Genomics is expanding rapidly in global sequencing services and genomics research. The company benefits from large-scale sequencing infrastructure and growing investments in advanced genomic technologies.
5. F. Hoffmann-La Roche
Roche has strengthened its genomics portfolio through acquisitions and strategic investments in sequencing technologies, including long-read applications. Its clinical diagnostics expertise positions the company strongly for future clinical genomics expansion.
6. QIAGEN
QIAGEN plays a major supporting role in long-read sequencing workflows through sample preparation, library preparation, and bioinformatics solutions. The company’s technologies help improve sequencing efficiency and downstream genomic analysis.
7. Thermo Fisher Scientific
Thermo Fisher Scientific maintains a strong genomics presence through sequencing instruments, reagents, consumables, and laboratory automation solutions. The company is investing strategically in advanced sequencing capabilities and partnerships.
8. Element Biosciences
Element Biosciences is emerging as an innovative sequencing company focused on high-performance genomic solutions. The company is gaining industry attention for developing cost-efficient alternatives in sequencing workflows.
Other Notable Companies in the Market
Several additional organizations contribute to the growth of long-read sequencing through reagents, sequencing services, automation, and specialized genomic applications:
- Takara Bio
- Agilent Technologies
- Eurofins Genomics
- 10x Genomics
- Loop Genomics
- Genapsys
- Nabsys
- Novogene
Why These Companies Matter
The long-read sequencing market is becoming increasingly important because conventional short-read sequencing often struggles with:
- Complex genomic regions
- Structural variants
- Repeat expansions
- Epigenetic modifications
- Large-scale genome assembly
Long-read technologies provide deeper genomic insights, which are critical for:
- Precision medicine
- Oncology research
- Rare disease diagnostics
- Agricultural genomics
- Infectious disease surveillance
- Drug discovery
Industry reports suggest that the market is expaning rapidly due to rising adoption of third-generation sequencing technologies and growing genomic research investments.
Future Outlook of the Long-Read Sequencing Industry
The competitive landscape is expected to intensify as companies focus on:
- Improving sequencing accuracy
- Reducing costs per genome
- Increasing throughput
- Expanding clinical applications
- Integrating AI-driven genomic analysis
- Developing portable and decentralized sequencing systems
Currently, Pacific Biosciences and Oxford Nanopore Technologies remain the most recognized leaders in pure long-read sequencing technology, while major genomics companies like Illumina and Roche continue investing aggressively to strengthen their positions in this rapidly evolving market.
Enquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=140422082